GE Healthcare to Distribute Osprey Medical’s Contrast-Reduction Technology in Europe and Other Regions
July 30, 2020—GE Healthcare and Osprey Medical Inc. announced a strategic alliance under which GE Healthcare will exclusively distribute Osprey’s product portfolio in Europe, Russia, the Middle East, Africa, Central Asia, and Turkey.
Canon Medical Introduces New Configuration of Aquilion One/Genesis Edition Cardiac CT Solution
July 17, 2020—Canon Medical Systems USA, Inc. announced the introduction of a new configuration of the Aquilion One/Genesis Edition, an artificial intelligence–powered wide-area CT system for structural and coronary imaging.
Abbott’s LightLab Initiative Shows OCT Imaging Changes Coronary Treatment Decisions
June 26, 2020—Abbott announced that the first data reported from the company’s LightLab Initiative showed that optical coherence tomography (OCT) imaging significantly changes how physicians decide to treat a vessel (compared to traditional angiography) by providing physicians improved visualization within a patient’s blood vessels.
CHOW NOW Study Compares Eating Versus Fasting Before Cardiac Catheterizations
May 14, 2020—The Society for Cardiovascular Angiography and Interventions (SCAI) announced findings from the single-center, randomized CHOW NOW study that aimed to compare the safety and clinical outcomes of a nonfasting (NF) strategy as compared with the current standard fasting (SF) protocol.
OCT Imaging Studied to Predict FFR Values in Coronary Lesions
May 14, 2020—The Society for Cardiovascular Angiography and Interventions (SCAI) announced findings from a study that sought to evaluate whether optical coherence tomography (OCT) parameters may predict fractional flow reserve (FFR) values and assess if OCT parameters may predict clinical outcome in patients with negative FFR.
SCAI Multisociety Position Statement Addresses Occupational Health Hazards in Catheterization Labs
February 11, 2020—The Society for Cardiovascular Angiography & Interventions (SCAI) multisociety position statement on occupational health hazards of the catheterization laboratory has been published by Lloyd W. Klein, MD, et al online in SCAI’s Catheterization & Cardiovascular Interventions.
Philips’ DEFINE GPS Trial Will Assess Outcomes of PCI Guided by an Integrated Platform of iFR and Angiogram
February 11, 2020—Royal Philips announced a new randomized controlled trial to assess patient outcomes after receiving percutaneous coronary intervention (PCI) guided by Philips’ coregistration platform (which combines data of instant wave-free ratio (iFR) measurement and angiography) compared with the standard of care treatment guided by angiography alone.
Study Validates FFR-Guided PCI in Patients With Acute Coronary Syndrome
November 29, 2019—Findings from a study evaluating the use of fractional flow reserve (FFR) assessment in acute coronary syndrome (ACS) were published by Jad Omran, MD, et al online ahead of print in Catheterization & Cardiovascular Interventions.
Five-Year IVUS-XPL Outcomes Support Intravascular Ultrasound-Guided EES Implantation
September 29, 2019—The 5-year follow-up results of the IVUS-XPL randomized trial were published online by Sung-Jin Hong, MD, et al in Journal of the American College of Cardiology (JACC): Cardiovascular Interventions simultaneously with their presentation in a late-breaking trial session at TCT 2019, the 31st annual Transcatheter Cardiovascular Therapeutics scientific symposium held September 25–29 in San Francisco, California.
Single-Center FORZA Trial Compares FFR and OCT Guidance for PCI
September 29, 2019—Findings from the FORZA trial were presented by Francesco Burzotta, MD, in a late-breaking trials session at TCT 2019, the 31st annual Transcatheter Cardiovascular Therapeutics scientific symposium held September 25–29 in San Francisco, California.
FDA Clears Siemens Healthineers' Artis icono Family of Angiography Systems
September 16, 2019—Siemens Healthineers announced FDA clearance for the Artis icono family of high-precision angiography systems that permit a wide range of minimally invasive procedures to be performed in a single interventional suite.
Canon Medical's Alphenix 4D CT System Introduced in the United States
July 22, 2019—Canon Medical Systems USA, Inc. announced the introduction of its Alphenix four-dimensional (4D) CT system with the first commercial installation at West Virginia University (WVU) Heart and Vascular Institute in Morgantown, West Virginia.
US Device Guide
This Device Guides offers a searchable, comprehensive listing of the available interventional cardiology devices in the United States.
European Device Guide
This Device Guides offers a searchable, comprehensive listing of the available interventional cardiology devices in Europe.